Cargando…

A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues

Malignant melanoma has the highest increase of incidence of malignancies in the western world. In early stages, front line therapy is surgical excision of the primary tumor. Metastatic disease has very limited possibilities for cure. Recently, several protein kinase inhibitors and immune modifiers h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Welinder, Charlotte, Pawłowski, Krzysztof, Sugihara, Yutaka, Yakovleva, Maria, Jönsson, Göran, Ingvar, Christian, Lundgren, Lotta, Baldetorp, Bo, Olsson, Håkan, Rezeli, Melinda, Jansson, Bo, Laurell, Thomas, Fehniger, Thomas, Döme, Balazs, Malm, Johan, Wieslander, Elisabet, Nishimura, Toshihide, Marko-Varga, György
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395420/ https://www.ncbi.nlm.nih.gov/pubmed/25874936 http://dx.doi.org/10.1371/journal.pone.0123661

Ejemplares similares

Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay
por: Welinder, Charlotte, et al.
Publicado: (2014)

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
por: Welinder, Charlotte, et al.
Publicado: (2017)

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
por: Welinder, Charlotte, et al.
Publicado: (2013)

Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
por: Sugihara, Yutaka, et al.
Publicado: (2018)

The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
por: Rezeli, Melinda, et al.
Publicado: (2011)

Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
por: Sanchez, Aniel, et al.
Publicado: (2019)

Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage
por: Malm, Johan, et al.
Publicado: (2013)

Clinical protein science in translational medicine targeting malignant melanoma
por: Gil, Jeovanis, et al.
Publicado: (2019)

Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies
por: Malm, Johan, et al.
Publicado: (2015)

Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
por: Kim, Yonghyo, et al.
Publicado: (2020)

Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies
por: Eriksson, Jonatan, et al.
Publicado: (2017)

Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study
por: Truedsson, Mikael, et al.
Publicado: (2016)

Primary Breast Cancer Tumours Contain High Amounts of IgA1 Immunoglobulin: An Immunohistochemical Analysis of a Possible Carrier of the Tumour-Associated Tn Antigen
por: Welinder, Charlotte, et al.
Publicado: (2013)

Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone
por: Gidlöf, Olof, et al.
Publicado: (2019)

Biobank resources for future patient care: developments, principles and concepts
por: Végvári, Ákos, et al.
Publicado: (2011)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
por: Marcell Szasz, A., et al.
Publicado: (2018)

The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2021)

The human melanoma proteome atlas—Defining the molecular pathology
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2021)

Matrix‐assisted laser desorption ionization ‐ mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non‐small‐cell lung cancer mouse xenograft model
por: Kim, Tae Young, et al.
Publicado: (2021)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas
por: Kelemen, Olga, et al.
Publicado: (2020)

Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Monitoring targeted drug delivery: a key cornerstone of precision medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

Identification and Validation of VEGFR2 Kinase as a Target of Voacangine by a Systematic Combination of DARTS and MSI
por: Kim, Yonghyo, et al.
Publicado: (2020)

Amyloid-specific extraction using organic solvents
por: Kamiie, Junichi, et al.
Publicado: (2020)

Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors
por: Torok, Szilvia, et al.
Publicado: (2017)

Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories
por: Nishimura, Toshihide, et al.
Publicado: (2014)

Clusterwise Peak Detection and Filtering Based on Spatial Distribution To Efficiently Mine Mass Spectrometry Imaging Data
por: Eriksson, Jonatan O., et al.
Publicado: (2019)

Building the basis for proteomics in personalized medicine for targeted treatment
por: Kwon, Ho Jeong, et al.
Publicado: (2016)

Visualisation of H(2)O(2) penetration through skin indicates importance to develop pathway-specific epidermal sensing
por: Jankovskaja, Skaidre, et al.
Publicado: (2020)

An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial Activation
por: Gil, Jeovanis, et al.
Publicado: (2021)

Non-invasive skin sampling of tryptophan/kynurenine ratio in vitro towards a skin cancer biomarker
por: Jankovskaja, Skaidre, et al.
Publicado: (2021)

A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references
por: Fukuda, Tetsuya, et al.
Publicado: (2017)

Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer’s Disease
por: Velásquez, Erika, et al.
Publicado: (2021)

A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types
por: Kato, Yasufumi, et al.
Publicado: (2015)

Correction: Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue
por: Murillo, Jimmy Rodriguez, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_coio8l54eln6u4l9jqq795gara